Canada's Economy, Explained
Calm Before the Storm: Canada’s Economic Outlook & Recession Risk with Dawn Desjardins
22 Apr 2025
In this episode, host Marwa Abdou speaks with Dawn Desjardins, Chief Economist at Deloitte Canada, about the country's fragile economic outlook for 2025. Desjardins shares insights from Deloitte’s Calm Before the Storm report, which highlights falling interest rates, stable inflation, and household savings as economic supports — while new U.S. tariffs and slowing immigration policies introduce serious risks.Desjardins warns that a potential 25% U.S. tariff on Canadian exports could cost the average Canadian over $2,000 annually, while GDP could shrink by 0.8% if Canada retaliates. “Consumer confidence has come down significantly,” she says, adding that businesses are delaying investments due to uncertainty. Labour shortages may ease with reduced immigration, but that could also dampen long-term growth. She also points to productivity issues, housing shortages, and geopolitical uncertainty as compounding pressures.Despite the turbulence, Desjardins remains cautiously optimistic: “We anticipate this to be a sharp impact on the economy, but a relatively short-lived one.”Resources:Deloitte Canada ReportBDL Business Conditions Terminal
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare